Theory‐based diabetes self‐management education with pre‐selection of participants: a randomized controlled trial with 2.5 years’ follow‐up (ELDES Study)

Por Vos, R. C., van Heusden, L., Eikelenboom, N. W. D., Rutten, G. E. H. M.
Publicado no Diabet Med (2019)

Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes

Por Manschot, S. M., Biessels, G. J., de Valk, H., Algra, A., Rutten, G. E. H. M., van der Grond, J., Kappelle, L. J.
Publicado em 2007

High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes

Por Boonman-de Winter, L. J. M., Rutten, F. H., Cramer, M. J. M., Landman, M. J., Liem, A. H., Rutten, G. E. H. M., Hoes, A. W.
Publicado em 2012

Does early intensive multifactorial therapy reduce modelled cardiovascular risk in individuals with screen-detected diabetes? Results from the ADDITION-Europe cluster randomized tr...

Por Black, J A, Sharp, S J, Wareham, N J, Sandbæk, A, Rutten, G E H M, Lauritzen, T, Khunti, K, Davies, M J, Borch-Johnsen, K, Griffin, S J, Simmons, R K
Publicado em 2014

Does early intensive multifactorial treatment reduce total cardiovascular burden in individuals with screen-detected diabetes? Findings from the ADDITION-Europe cluster-randomized...

Por Simmons, R K, Sharp, S J, Sandbæk, A, Borch-Johnsen, K, Davies, M J, Khunti, K, Lauritzen, T, Rutten, G E H M, van den Donk, M, Wareham, N J, Griffin, S J
Publicado em 2012

Cost-effectiveness of intensive multifactorial treatment compared with routine care for individuals with screen-detected Type 2 diabetes: analysis of the ADDITION-UK cluster-random...

Por Tao, L, Wilson, E C F, Wareham, N J, Sandbæk, A, Rutten, G E H M, Lauritzen, T, Khunti, K, Davies, M J, Borch-Johnsen, K, Griffin, S J, Simmons, R K
Publicado no Diabet Med (2015)

Research: Educational and psychological aspects Patient-reported outcomes after 10-year follow-up of intensive, multifactorial treatment in individuals with screen-detected type 2...

Por Dalsgaard, E.-M., Sandbæk, A., Griffin, S. J., Rutten, G. E. H. M., Khunti, K., Davies, M. J., Irving, G. J., Vos, R. C., Webb, D. R., Wareham, N. J., Witte, D. R.
Publicado no Diabet Med (2020)

Non-fasting lipids and risk of cardiovascular disease in patients with diabetes mellitus

Por van Dieren, S., Nöthlings, U., van der Schouw, Y. T., Spijkerman, A. M. W., Rutten, G. E. H. M., van der A, D. L., Sluik, D., Weikert, C., Joost, H. G., Boeing, H., Beulens, J. W. J.
Publicado em 2010

External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes

Por van Dieren, S., Peelen, L. M., Nöthlings, U., van der Schouw, Y. T., Rutten, G. E. H. M., Spijkerman, A. M. W., van der A, D. L., Sluik, D., Boeing, H., Moons, K. G. M., Beulens, J. W. J.
Publicado em 2010

Physical Activity and Characteristics of the Carotid Artery Wall in High‐Risk Patients—The SMART (Second Manifestations of Arterial Disease) Study

Por Boss, H. Myrthe, van der Graaf, Yolanda, Visseren, Frank L. J., Van den Berg‐Vos, Renske M., Bots, Michiel L., de Borst, Gert Jan, Cramer, Maarten J., Kappelle, L. Jaap, Geerlings, Mirjam I., van Petersen, R., Dinther, B. G. F., Algra, A., Grobbee, D. E., Rutten, G. E. H. M., Leiner, T., Doevendans, P. A.
Publicado no J Am Heart Assoc (2017)